Non-interventional Study on Compliance of Inhaled Treatment With Ventavis in Patient With Pulmonary Hypertension

• Status: Completed
• Trial end date: 2018-04-18
• Target enrollment: 0
• Participant gender: All

Summary

Local, prospective, multicenter, non-comparative, non-interventional, observational study. It is planed to assess compliance of patients with PH (pulmonary hypertension) with the physician's recommendation in real practice.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Bayer
• Treatments: Iloprost

Criteria

Inclusion Criteria:

• Male and female patients ≥ 18 years old

• Diagnosis of PH

• Planned or current treatment with Ventavis (not more than 6 month)

Exclusion Criteria:

• Contraindications for the use of Ventavis in accordance with the local product information